Severs Disease Treatment Market - Trends, Size & Outlook (2024-2032)

Severs Disease Treatment Market Synopsis:

Severs Disease Treatment Market Size Was Valued at USD 3.9 Billion in 2023 and is Projected to Reach USD 5.4 Billion by 2032, Growing at a CAGR of 3.7 % From 2024-2032.

Sever’s Disease Treatment Market is a niche segment in the medical and orthopedic device market dedicated to addressing the unmet medical needs related to Sever’s disease or calcaneal apophysitis. Sever’s disease is an overuse syndrom where the heel is painful in children and adolescent athletes particularly at any age of increased skeletal growth and during sports. This condition develops from the inflammation of the growth plate in the heel bone through repetitive stress, which occasion discomfort and limitation in mobility.

The market for Sever’s Disease Treatment plays an important part in paediatric orthopaedics, as there is a need for proper form of treatment option for Sever’s disease or more accurately calcaneal apophysitis. Sever’s disease is an acute inflammatory disorder that affects children, adolescents specifically those in the growing phase of the sport-related activities or exercises. These therapeutic products consist of non invasive devices including orthotic insoles and heel cups to medical services including physical therapy which involves building of muscle and tendons to take pressure off the heel. NSAIDs necessary for pain control, cold therapy products including ice packs are equally important components of this symptomatic medication of childhood rheumatic diseases as mild, moderately or severely affected cases can be seen in children. These products and services are very useful in decreasing the patient’s pain, increasing the range of the patient’s motion and allowing the young athlete to get back into their sports without exacerbation of the injury.

The largest source of expansion of the market depends on the growing frequency of sports traumas in children and parental and medical interest in prevention measures. Technological innovations concern with the orthopedic devices that include ergonomic and supportive shoe for kids continue to drive the expansion of the market by providing specific design to fit a child’s biomechanics. Besides, due to the increasing concern by parents to ensure that their children practice safe sports and the general desire to prevent injuries, there has been increased uptake in items such as orthotic devices and physical therapy services. It is anticipated that this market will sustain its growth as knowledge of the condition strengthens, and as more choices designed for children are offered. The focus on minimally invasive and nonsurgical intervention also complies with the current treatment philosophy that aims at preservative and least invasive care for children.Bottom of Form

Severs Disease Treatment Market Trend Analysis:

Rising Demand for Non-Invasive and Customized Treatments

• Sever’s Disease Treatment Market has done observing a considerable shift towards non-surgical and personalized treatments since more parents and healthcare professionals look for a path through effective pediatric treatment choices. Parents and medical professionals alike have sought improved orthopedic modification into products such as heel cups, comfortable shoes and foot orthoses that would allow the child to have the right anatomical fulfillment without over straining their heels or experiencing repeated shock impacts. There is also an emerging interest raised towards provoking physical therapy and rehabilitation services since it consists of exercising programs for Achilles tendon and calf muscle that seeks to cure the problem in the long run without involving the use of drugs. This trend fits well into current shifts toward a greater focus on primary and secondary prevention in child and youth healthcare. Moreover, material science and ergonomic designs for orthotic products have improved to be more comfortable, durable and affordable; this in way has made it easier for people to access the non-surgical treatments.

Expanding Telehealth Services 

• This scheduling issue creates a significant new growth opportunity within Sever’s Disease Treatment Market due to the increased availability of telehealth, which allows parents of children diagnosed with Sever’s Disease more options for receiving specialized care irrespective of their geographical location. Telehealth enables healthcare givers like paediatric orthopaedists and physical therapist to remotely evaluate conditions, prescribe exercises and monitor progress; important for those in rural or underdeveloped areas. Other non-pharmacological interventions which may be advised by a health care provider during home based consultation include: stretching regimen; choice of shoes; and use of orthoses. This transformation also helps the continuous support and conveniently keeps children on track with their planned therapy sessions and modifications on their prescribed plan. In addition, as wristbands, clay bands, mobile applications, and other wearables expand, the telehealth can link up real time and give clinicians more accurate information which they can use enhance the process to provide superior results.

Severs Disease Treatment Market Segment Analysis:

Severs Disease Treatment Market is Segmented based on type of Disease, Drug, Route of Administration, and Region

By Type, the disease segment is expected to dominate the market during the forecast period

• In terms of type the disease segment is expected to dominate the sever’s disease treatment market between 2017 and 2023 due to rise in disease among children and adolescent sports and physically active people. Due to its prevalence as a heel pain cause in young and more physically active individuals, Sever’s disease has fostered consumer demand and market development of treatment options that specifically target these biomechanically and physiologically demanding patients. It comprises foot and orthopaedic devices like heel cups, cushioned insole mid arch support, braces, combinations with physical therapy and other pain management solutions, which do not put any pressure on the growth plate of the heel and provide long term relief. An important finding regarding Sever’s disease was that parents and healthcare professionals are actively looking for early treatment methods for heel pain in children because if left untreated the condition affects the child’s comfort and movement for a long time. 

By Drug, diclofenac segment expected to held the largest share

• Regarding the drug segment in the Sever’s Disease Treatment Market, diclofenac is expected to dominate the market during the generation of the report. Oral medication such as Diclofenac, an NSAID, is recommended for patients suffering from inflammation and pain affecting their heels due to Sever’s disease with children being recommended for moderate to severe pain. The rationale for its use in the management of Sever’s disease is because it is a non-steroidal anti-inflammatory drug that relieves sever pain quickly and has an anti-inflammatory effect on the growth plate of the heel.
• Among all the drugs available in the Sever’s Disease Treatment Market, diclofenac will dominate the market in the future. Non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac are usually recommended for children in the treatment of inflammation and pain caused by Sever’s disease. This is because it is both analgesic and anti-inflammatory, thereby relieves the pain caused by Sever’s disease and also halt inflammation of the growth plate of the heel.

Severs Disease Treatment Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is expected to account for the largest share in the Sever’s Disease Treatment Market over the upcoming period due to factors such as higher awareness, qualified health care systems, and more vulnerable population belonging to the young athletes category affected by Sever’s disease. Since the United States presently ranks highest for children and adolescents participation in sports, there is a rising trend of sports injuries including Sever’s disease that commonly affect children who take part in running, soccer, gymnastics, and other similar activities. Due to the regions healthcare maturity, the diagnosis is quick, and the patient has access to many treatments like physical therapy, over-the-counter products like diclofenac, new orthogonal devices aimed to combat heel pain among others.

 Active Key Players in the Severs Disease Treatment Market:

• AdvaCare Pharma (United States)
• Bayer AG (Germany)
• Breg, Inc. (United States)
• DJO Global, Inc. (United States)
• GlaxoSmithKline plc (United Kingdom)
• Halyard Health, Inc. (United States)
• Johnson & Johnson (United States)
• Medline Industries, Inc. (United States)
• Novartis AG (Switzerland)
• Pfizer Inc. (United States)
• Sanofi S.A. (France)
• Smith & Nephew plc (United Kingdom)
• Stryker Corporation (United States)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Zimmer Biomet Holdings, Inc. (United States)
• Other Active Players